SecBot SecBot
SECBOTREPLAY Home › Report › NBIX

NBIX · Director George J

NEUROCRINE BIOSCIENCES INC · 144 filed Nov 2, 2026 at 16:38 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 2, 2026 at 16:38 ET

Director George J. Morrow filed a Form 144 notice of intent to sell 14,700 shares of Neurocrine Biosciences common stock, with an approximate market value of $2.15 million based on the filing date. The shares are to be received upon exercise of stock options, and the sale is planned under a Rule 10b5-1 trading plan adopted on May 26, 2026.

  • Director George J. Morrow filed Form 144 to sell 14,700 shares of Neurocrine Biosciences common stock.
  • The approximate market value of the proposed sale is $2,147,670.
  • Shares will be acquired upon exercise of stock options.
  • The sale is planned under a Rule 10b5-1 trading plan adopted on May 26, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access